Drug Utilization Review Board

The DUR Board provides evaluation of criteria for drug coverage within the Medicaid Program. The Board is composed of Physicians & Pharmacist professionals who meet on a monthly basis to consider issues that affect how drugs are provided by the Medicaid program. These meetings are held on the second Thursday of every month at 7:00 A.M. in the Cannon Health Building at 288 N. 1460 W. in Salt Lake City, UT. Notices for exact meeting times and locations will be published in the Legal Notices sections of the Salt Lake Newspapers at least 30 days in advance.

The meetings are open to the public. To receive public notice for this meeting by email please sign up on the Utah Public Notice website.

Listed below are meeting minutes, recording, agendas, criteria review documents, and reports regarding the DUR Board. Criteria review documents prepared for the DUR Board meetings will be kept on this website for 6 months.

Meeting recordings will be available online for 1 year. For historical meeting recordings please contact us at medicaidpharmacy@utah.gov.

Current Criteria Review Documents available include:

February 2014: Neuraminidase Inhibitors (Tamiflu/Relenza)
March 2014: Hepatitis C Drug Review (all PA criteria removed, No Criteria Review Documentation)
April 2014: Phosphodiesterase-4 Inhibitor(s) (Roflumilast)
May 2014: Miscellaneous Lipid-Lowering Agents (Juxtapid/Kynamro)
June 2014: No Meeting (No Criteria Review Documentatio)
July 2014: Hepatitis C (Sovaldi/Olysio) (see updated PA criteria sheets, No Criteria Review Documentation)
August 2014:Proton Pump Inhibitor (PPI) Agents
September 2014: Topical Immunomodulator Agents
October 2014: OIG Presentation (No Criteria Review Documentation

The documents are provided in Adobe format. If you cannot view a file, please download the free plug-in from the link below.

Get Adobe Reader